ZD6474 (ZACTIMA™) Phase III Study in EGFR Failures (Q65473576)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | ZD6474 (ZACTIMA™) Phase III Study in EGFR Failures |
clinical trial |
Statements
A Phase III Study to Assess the Efficacy of ZD6474 (ZACTIMA™) Plus Best Supportive Care Versus Best Supportive Care in Patients With Locally Advanced or Metastatic (Stage IIIB-IV) Non-Small Cell Lung Cancer After Therapy With an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR TKI) (English)
0 references
November 2006
0 references
October 2009
0 references
1,140
0 references
18 year
0 references